Discover the reasons behind recurring nosebleeds beyond dry air, including medication effects, clotting disorders, structural ...

Tectonic Therapeutic, Inc.’s TECX share price has dipped by 6.52%, which has investors questioning if this is right time to buy.

TX2100 targets hereditary hemorrhagic telangiectasia with promising preclinical data, aiming for a Phase 1 launch in late 2025 or early 2026. Financially, TECX has a strong cash position to fund ...

When a patient presented with challenging nosebleeds and severe gastrointestinal bleeding—hallmarks of Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic disorder affecting blood vessel ...

in reducing abnormal blood vessel formation in patients with hereditary hemorrhagic telangiectasia harboring brain AVMs.30 Early phase clinical trials are also in process for non-familiar brain AVMs.

A gastrointestinal cause of anaemia was suspected and oesophagogastroduodenoscopy (OGD) was performed, revealing multiple reddish lesions in the gastric fundus, body and antrum as well as in the ...

More information: Yaël P. Mossé et al, Anaplastic Lymphoma Kinase Inhibition Therapy for Hereditary Neuroblastoma, JCO Precision Oncology (2025). DOI: 10.1200/PO-24-00886 Journal information ...

Completed Approximately $185.0 Million Private Placement: In February 2025, Tectonic entered into a securities purchase agreement for a private investment in public equity financing ("PIPE”) that ...

LONDON — Some of Britain’s hereditary peers are already planning a comeback to the House of Lords despite the ruling Labour Party’s plans to boot them out. Peers from multiple parties have discussed ...

Thank you. I’m going to use this time to cover a really common postpartum complication that can be really devastating to women, and it is called postpartum hemorrhage. And there are a few points ...

Charlie Courtenay, the 19th or 38th Earl of Devon, depending on how you count it, is one of the 87 remaining hereditary peers who will be kicked out of the House of Lords this year, if the ...